Yuanta Investment

Yuanta Investment is a venture capital investment firm established in 1989 and headquartered in Seoul, South Korea. The company focuses on identifying and nurturing potential growth opportunities within various sectors, primarily through private equity investments. By leveraging its expertise and resources, Yuanta Investment aims to enhance the development of emerging companies, facilitating their ascension in the market. The firm is dedicated to fostering innovation and supporting entrepreneurs in their endeavors, contributing to the overall growth of the economy in the region.

Mook Choi

Senior Manager, Venture Capital

Matthew Choi

Managing Director

SangWoon Hwang

CEO

David Jang

Manager, Venture Capital

Vincent Jeong

Managing Director and Head of Venture Capital

Byungwoo Kim

Managing Director, Private Equity

Sang-Woo Park

Managing Director

Steve Park

Managing Director

JoonSang Yoo

Managing Director

44 past transactions

Selta Square

Series A in 2025
Selta Square is an AI-based company specializing in drug monitoring solutions. It has developed an intelligent pharmacovigilance platform that leverages advanced artificial intelligence and digital technologies. The platform aims to enhance the efficiency of pharmacovigilance professionals by automating repetitive tasks, allowing them to concentrate on critical responsibilities. This enables systematic and scientific management of adverse cases and medical evaluations related to pharmaceuticals, ultimately improving the safety and efficacy of medicines.

Pin Therapeutics

Series C in 2024
Pin Therapeutics, Inc. is a biotechnology company founded in 2017 and based in South San Francisco, California. The company specializes in developing therapeutic products that utilize protein degradation technology to target and break down disease-causing proteins. Pin Therapeutics focuses on treating immune diseases, cancer, and age-related conditions. Its drug discovery efforts include programs centered on novel molecular glue degraders and a PROTAC program, aimed at addressing specific medical needs and enhancing treatment efficacy. The company employs a diverse team of scientists and leaders with experience from global pharmaceutical and biotech firms, and it operates with a notable presence in both the United States and Korea. Pin Therapeutics is committed to advancing drug discovery through innovative screening systems and platforms that improve biological specificity for targeted protein degradation.

Mepsgen

Series C in 2024
Mepsgen is a biotechnology research organization that focuses on pharmaceutical services and drug development.

Panmnesia

Series A in 2024
Panmnesia is a Korean chip startup. It is focused on developing intellectual property around a technology, which allows big data center operators to pool devices such as AI accelerator chips, processors, and memory.

RideFlux

Series B in 2024
RideFlux Inc. is a South Korean company specializing in the development of self-driving technology for automobiles. Founded in 2018 and headquartered in Jeju Island, RideFlux focuses on creating safe and reliable autonomous transportation services. The location serves as an ideal testing ground for their technology, offering diverse road environments and varying weather conditions, which are essential for developing effective autonomous driving software. The company aims to transform driving into a more innovative and stress-free experience, addressing the growing demand for mobility services, particularly in high-traffic tourist areas. RideFlux's offerings include autonomous driving services, remote control solutions, and high-precision mapping, all designed to enhance both safety and efficiency in transportation.

Inventera Pharmaceuticals

Series C in 2024
Inventera Pharmaceutical is a biotechnology company that specializes in the development of imaging diagnostic contrast agents.

Rznomics

Venture Round in 2024
Rznomics is a biotechnology company founded by professor Lee Sung-wook's lab, focusing on the development of innovative gene therapy products aimed at treating liver cancer and other serious medical conditions. The company specializes in ribonucleic acid-based therapies that address significant unmet medical needs, particularly in the areas of cancer, degenerative neurological disorders, and hereditary diseases. By creating new biopharmaceuticals, Rznomics aims to provide medical practitioners with effective treatment options for challenging health issues, including various types of cancer and Alzheimer’s disease. The company has garnered recognition for its technological excellence, having been selected for the TIPS program, which highlights its commitment to advancing medical science.

FASSTO

Series D in 2024
FASSTO is a consulting company that specializes in providing fulfillment services for online merchants. The company focuses on packaging, delivery, logistics, and shipping solutions tailored to meet the needs of businesses, particularly those with limited resources. By leveraging digital technologies such as artificial intelligence and big data, FASSTO creates a user-friendly environment that allows small-scale sellers, including one-person operations and those shipping individual items, to efficiently manage their shipping processes. This approach helps clients save time and money, enabling them to concentrate on other critical areas of their business.

ADEL

Series B in 2024
The company is a spin-off from Asan Medical Center, University of Ulsan University, with a primary objective of developing therapeutic and diagnostic agents for neurological diseases, particularly Alzheimer's disease. In 2016, the company took significant steps toward formalizing its presence in the market by completing its incorporation and business registration processes. The year 2017 proved to be a milestone for the company as it obtained certification as a corporate-affiliated research institute, solidifying its position as a reputable research-driven organization. Additionally, it garnered recognition as a leading university start-up by the Ministry of SMEs and Startups, further boosting its credibility and potential for growth. The company has collaborated with Oscotech Co., Ltd. and partnered with various investors, including Kite Entrepreneurship Foundation, Stone Bridge Ventures Co., Ltd., Korea Development Bank, and Stick Ventures Co., Ltd., to jointly develop their projects.

Panmnesia

Seed Round in 2023
Panmnesia is a Korean chip startup. It is focused on developing intellectual property around a technology, which allows big data center operators to pool devices such as AI accelerator chips, processors, and memory.

K-NETZ

Series A in 2023
K-NETZ is an IT company that provides value-oriented R&D and possesses global technological competitiveness services.

Nexel

Venture Round in 2023
Nexel is a biotechnology research firm focused on advancing drug discovery and biotherapeutics. The company specializes in developing high-quality induced pluripotent stem cell (iPSC) products using embryonic stem cell technology. By providing innovative solutions and drug discovery pipelines, Nexel aims to address unmet medical needs and enhance therapeutic options for various diseases.

Eloi MateriaLs

Seed Round in 2023
Eloi MateriaLs is a materials technology firm that focuses on advanced alloys, metal powders, PVD coatings, and metal 3D printing.

THE PIRATES

Series C in 2022
The Pirates Co., Ltd. specializes in the development and operation of a mobile application that serves both wholesale and retail markets for seafood products. Established in 2018 and headquartered in Seoul, South Korea, the company also operates an aquatic market news platform that delivers information on fresh seafood offerings. This platform connects consumers with suppliers, providing essential insights into the quality of marine products and facilitating informed purchasing decisions. Through its innovative approach, The Pirates aims to enhance the seafood purchasing experience by bridging the gap between consumers and the fish market.

Cureverse

Series A in 2022
Cureverse operates a pharmaceutical research and development company for the treatment of encephalopathy and oncology diseases. The company focuses on creating remedies for challenging brain conditions like dementia, thereby assisting healthcare professionals in enhancing human well-being and overall quality of life.

Neonesia

Series B in 2022
NeoNesia is a marketplace and software as a service (SaaS) company that facilitates the buying and selling of prepaid top-ups for small and medium enterprises (SMEs) in Indonesia. It operates a B2B e-commerce platform that empowers these businesses by providing a prepaid charging distribution system. Additionally, NeoNesia offers a digital payment portal and a platform for purchasing digital products, allowing customers to buy products online while enabling businesses to efficiently sell their digital offerings. Through its services, NeoNesia aims to enhance the digital transaction capabilities of SMEs in the Indonesian market.

Cellico

Seed Round in 2022
Cellico is a medical device company focused on creating innovative solutions for vision loss. The company specializes in the development of electronic eyeglasses and augmented reality glasses designed specifically for visually impaired individuals. By integrating advanced technology, including microelectronic components, Cellico aims to enhance human health and improve the quality of life for users. Through its commitment to innovation in bio and healthcare devices, the company is working to transform the landscape of assistive technologies for those with visual impairments.

FASSTO

Series C in 2022
FASSTO is a consulting company that specializes in providing fulfillment services for online merchants. The company focuses on packaging, delivery, logistics, and shipping solutions tailored to meet the needs of businesses, particularly those with limited resources. By leveraging digital technologies such as artificial intelligence and big data, FASSTO creates a user-friendly environment that allows small-scale sellers, including one-person operations and those shipping individual items, to efficiently manage their shipping processes. This approach helps clients save time and money, enabling them to concentrate on other critical areas of their business.

iN Therapeutics

Series B in 2022
iN Therapeutics is a biotechnology company focused on developing innovative drug therapies for patients with incurable neurological diseases. The company is engaged in the creation of treatments targeting various conditions, including non-narcotic analgesics for Nav1.7, hearing loss, and other brain-related disorders. By advancing its drug development pipeline, iN Therapeutics aims to provide effective solutions for central nervous system diseases, ultimately enhancing the quality of life for affected individuals.

Kukka

Series B in 2022
Kukka, Inc. is a South Korean company that specializes in flower sales for various settings, including office spaces, showrooms, and events. Established in 2014 and based in Seoul, Kukka offers a range of services, such as flower subscription, bouquet delivery, same-day delivery, and custom floral design. The company aims to promote the enjoyment of flowers in everyday life, reflecting Finnish cultural values. In addition to individual customer services, Kukka also provides corporate flower solutions and floral decoration for events. Customers can conveniently order fresh flowers online, and the company further engages with its clientele through flower art classes and related accessories.

i.M

Series A in 2022
i.M is a lifestyle mobility service that offers online platform and app for cab rides and vehicle rentals.

Dealicious

Series C in 2022
Dealicious operates as an online marketplace designed to connect fashion wholesalers and retailers on a global scale. By facilitating direct access to a vast selection of quality merchandise, including clothing, bags, shoes, and accessories, Dealicious streamlines the wholesale purchasing process. The platform primarily focuses on the Dongdaemun fashion district in South Korea, renowned for its concentration of fashion manufacturing and distribution within a compact area. With approximately 11,000 registered wholesale stores, Dealicious enables retailers to browse and order from a diverse array of items, with 24,000 new products added daily. This approach eliminates the need for retailers to visit physical markets, allowing them to save valuable time and resources. Dealicious is committed to enhancing the user experience by continuously developing customer-centric services that ensure seamless access to high-quality products in the Korean fashion market.

Yeoshin

Series B in 2021
Yeoshin is a skin treatment information platform.

AMCG

Series A in 2021
AMCG is a developer of medical diagnostic devices focused on detecting cardiac-related conditions. The company leverages applied computer science, artificial intelligence, and big data to create innovative diagnostic imaging platforms. These technologies enhance the accuracy and efficiency of image diagnosis, thereby enabling healthcare professionals to identify and assess various medical conditions, particularly heart diseases. By integrating advanced methodologies into their diagnostic devices, AMCG aims to improve patient outcomes and support medical practitioners in delivering effective healthcare solutions.

Kasa

Venture Round in 2021
Kasa Korea Co., Ltd. is a company based in Seoul, South Korea, that specializes in developing a digital securities blockchain platform tailored for the real estate market. Established in 2018, Kasa's platform enables users to buy and trade securitized commercial real estate assets as asset-backed securities. By leveraging blockchain technology, the company aims to provide retail investors with a transparent and streamlined process for investing in real estate, facilitating the buying and selling of securitized assets in a more efficient manner.

Tiki

Series E in 2021
Tiki is an e-commerce company that operates a comprehensive platform offering a diverse range of products across multiple categories. With over 300,000 items available, Tiki partners with various brands to ensure a wide selection that includes electric appliances, fashion accessories, mobile devices, and health products. The company's focus on efficient logistics and customer service aims to enhance customer satisfaction while providing a secure shopping experience. By consolidating numerous product categories into a single platform, Tiki enables consumers to conveniently access a variety of items, catering to their diverse shopping needs.

iN Therapeutics

Series A in 2021
iN Therapeutics is a biotechnology company focused on developing innovative drug therapies for patients with incurable neurological diseases. The company is engaged in the creation of treatments targeting various conditions, including non-narcotic analgesics for Nav1.7, hearing loss, and other brain-related disorders. By advancing its drug development pipeline, iN Therapeutics aims to provide effective solutions for central nervous system diseases, ultimately enhancing the quality of life for affected individuals.

Perfect Storm

Series A in 2021
Perfect Storm is a digital content and marketing solution company based in Korea. It specializes in social media marketing services aimed at enhancing advertising effectiveness. The company offers technology that integrates augmented reality and virtual reality effects into simple notification service platforms. This innovative approach allows consumers to engage with brand products and services in an interactive and enjoyable manner, thereby helping businesses to boost their revenue.

Gbike

Series B in 2021
Gbike is a mobility sharing startup in Korea, innovating green urban mobility in Korea where currently car-centric environment. Our service includes bike and scooter sharing with IT services specialized for Korean market & Asia, Pacifics.

3billion

Series C in 2021
3billion, Inc. offers genetic testing and analysis services specifically designed for patients with rare diseases. Founded in 2016 and headquartered in Seoul, South Korea, the company aims to alleviate the challenges faced by these patients during the diagnostic process. By leveraging bioinformatics and machine learning technology, 3billion has significantly reduced the time and cost associated with genome interpretation, making comprehensive genetic testing more accessible. Their artificial intelligence-driven diagnostic services cover a wide range of genes and diseases, facilitating faster and more accurate diagnoses for healthcare providers, ultimately leading to improved health outcomes for patients.

SolarConnect

Series C in 2021
SolarConnect, Inc. is a company based in Seoul, South Korea, specializing in solar energy and information technology-based energy solutions. Founded in 2016, SolarConnect operates solar energy plants and provides installation services for solar panels in residential buildings and apartments. The company's expertise encompasses both the solar and energy industries, focusing on delivering innovative financial and IT solutions to enhance energy efficiency and sustainability.

N.CODE

Series B in 2021
N.CODE provide luxury goods of diverse brands through affiliation with European luxury boutiques. In addition to brand diversity, “d.code” guarantees provision of the sufficient and accurate information of brand information, product description, and price. They cover more than 700 luxury brands and 100K items. Second, they ensure reasonable price and quality service.

Shaperon

Series C in 2020
Shaperon Inc. is a biotechnology company based in Seoul, South Korea, founded in 2008, that specializes in the research and development of innovative therapeutics targeting chronic inflammatory diseases. The company focuses on creating inflammasome inhibitors and nanobody therapeutics designed to address conditions such as atopic dermatitis, systemic inflammatory response syndrome, and neuroinflammatory diseases. Shaperon offers a variety of drug candidates, including a gel-type formulation for treating atopic dermatitis and other related inflammatory conditions. In addition to its drug development efforts, the company is involved in providing immunotherapeutic products, including single-domain neutralizing antibodies, aimed at enhancing the quality of life for patients suffering from chronic inflammation and related ailments.

Lmito Therapeutics

Series A in 2020
Lmito Therapeutics Inc., founded in 2017 and based in Seongnam-si, South Korea, is a clinical-stage biopharmaceutical company focused on modulating cell metabolism to develop innovative immunotherapeutic compounds. The company specializes in creating mitochondrial drugs aimed at addressing metabolic syndromes, age-related neurodegenerative diseases, and mitochondrial respiratory chain disorders. Lmito Therapeutics is dedicated to developing treatments that regulate the metabolism of immune cells in the brain, as well as compounds for auto-inflammatory and autoimmune diseases. By focusing on the intersection of immunology, neuro-immunology, and immuno-oncology, Lmito Therapeutics aims to provide effective therapies for various neurological disorders and contribute to advancements in cancer treatment.

Cardoc

Private Equity Round in 2020
Cardoc Inc. is a mobile application company based in Seoul, South Korea, that specializes in car body repair services. Founded in 2013, the application allows users to upload photographs of their vehicle's exterior damage to receive real-time repair estimates and consultations from selected car body shops. Cardoc facilitates a user-friendly experience, enabling customers to obtain their first repair estimate within an average of seven minutes and compare multiple estimates without requiring personal information. Over a service period of 15 months, the company processed transactions worth $3.5 million, with participating repair shops experiencing significant monthly growth. Additionally, Cardoc offers a range of vehicle management services, including regular automobile inspections, car washes, and renewal services, which can be reserved online or at car centers. The founding team comprises automotive enthusiasts who received backing from a startup incubation organization, enhancing their growth and development in the automotive repair sector.

THE PIRATES

Series B in 2020
The Pirates Co., Ltd. specializes in the development and operation of a mobile application that serves both wholesale and retail markets for seafood products. Established in 2018 and headquartered in Seoul, South Korea, the company also operates an aquatic market news platform that delivers information on fresh seafood offerings. This platform connects consumers with suppliers, providing essential insights into the quality of marine products and facilitating informed purchasing decisions. Through its innovative approach, The Pirates aims to enhance the seafood purchasing experience by bridging the gap between consumers and the fish market.

First Canvas

Series A in 2020
First Canvas is a media company focused on addressing the marketing needs of businesses. The company offers a range of services, including content creation, distribution on social media platforms, performance advertising, and influencer marketing. By providing these services, First Canvas enables businesses to implement advertising campaigns efficiently and achieve effective results within a short timeframe.

ZigBang

Venture Round in 2019
ZigBang Co., Ltd. is a property listing platform and application based in Seoul, South Korea, which connects real estate agents with renters. Founded in 2010, the company operates a real estate marketplace that facilitates apartment hunting through its mobile and web platforms. Users can search for rental properties based on various criteria, including the number of rooms, occupants, and price. ZigBang has reported a user base of approximately 6 million, providing a comprehensive tool for individuals seeking rental accommodations while aiming to optimize their search and potentially reduce housing costs.

Together Funding

Series B in 2019
Together Funding is a provider of a peer-to-peer financial service platform that connects lenders, investors, and borrowers. The platform focuses on real estate collateral, facilitating online interactions where users can apply for loans and invest in financial products. By streamlining the process of matching borrowers with investors, Together Funding aims to help its users achieve their financial goals in a convenient and efficient manner.

APR Corporation

Series B in 2018
APR is a global beauty-tech company expands beyond beauty with “Medicube” leading the charge.

Beatrain

Post in 2018
Beatrain is a mobile game development company that specializes in creating and publishing casual social games for mobile platforms. The company's diverse portfolio features a variety of engaging titles, including cooking puzzles, Soul Knights, Baba Penguin, Warrior Goes, Trinity Master, and Elysion Saga. By focusing on entertaining gameplay, Beatrain aims to deliver enjoyable experiences to gamers.

Perfect Corp.

Series A in 2017
Perfect Corp. is a technology company specializing in augmented reality (AR) and artificial intelligence (AI) solutions for the beauty and fashion industries. Founded in 2014 and headquartered in New Taipei, Taiwan, with an additional office in San Jose, California, the company develops innovative platforms that enhance the shopping experience for consumers and brands alike. Perfect Corp. offers YouCam for Web, which provides makeup try-on plugins for e-commerce, and YouCam for Enterprise, a comprehensive suite of beauty solutions that includes virtual makeup application, AR skin diagnostics, and AI-driven product recommendations. Additionally, the company has created consumer-focused mobile applications such as YouCam Makeup and YouCam Perfect, which enable users to virtually try on products, perform skin analyses, and connect with a community of beauty enthusiasts. By partnering with leading brands, Perfect Corp. aims to transform traditional retail into engaging digital experiences.

Gorilla Technology

Series B in 2009
Gorilla Technology Group, Inc. is a technology company based in Taipei, Taiwan, specializing in video analytics, IoT security, and big data solutions. Founded in 2001, the company focuses on delivering business intelligence insights that enhance performance in sales, operations, and customer understanding. Its AI-driven platforms utilize machine learning and deep learning algorithms to identify and analyze digital content, enabling clients across various sectors, including healthcare, transportation, manufacturing, and retail, to make informed business decisions. Gorilla Technology's offerings also encompass network security and operational technology security solutions, addressing the diverse needs of commercial, industrial, municipal, and governmental clients. Notable clients include Shanghai Media Group, highlighting the company's capability to serve significant organizations.

Bionoxx

Bionoxx Inc. is a cancer immunotherapy company based in Seongnam-si, South Korea, focused on developing innovative treatments using oncolytic viruses. The company offers several therapeutic products, including OTS-412 and mOTS-412, as well as universal tumor targeting antigens (UTTA) for solid tumor eradication, specifically the UTTA CAR-T and UTTA BsAb. Additionally, Bionoxx is engaged in research on oncolytic vaccinia virus therapies, incorporating myeloid modulation technology to enhance immune responses. Their approach aims to create immune regulation-based anticancer drugs that improve patient outcomes in the fight against cancer.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.